Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. (Q52859590)

9 May 2018

title

Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. (English)

1 reference

9 May 2018

author

Colin Dunstan

8

1 reference

9 May 2018

Simon R. Carding

11

1 reference

9 May 2018

Sheena Cruickshank

2

object named as

S M Cruickshank

1 reference

9 May 2018

author name string

A J Ashcroft

1

1 reference

9 May 2018

P I Croucher

3

1 reference

9 May 2018

M J Perry

4

1 reference

9 May 2018

S Rollinson

5

1 reference

9 May 2018

J M Lippitt

6

1 reference

9 May 2018

J A Child

7

1 reference

9 May 2018

P J Felsburg

9

1 reference

9 May 2018

G J Morgan

10

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 December 2003

1 reference

9 May 2018

published in

Immunity

1 reference

9 May 2018

volume

19

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

page(s)

849-861

1 reference

9 May 2018

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

The effect of a single dose of osteoprotegerin in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Migration and maturation of human colonic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

RANK is essential for osteoclast and lymph node development

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Interleukin-2 and human monocyte activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

The clinical impact of metabolic bone disease in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Development and maturation of secondary lymphoid tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Activated T lymphocytes support osteoclast formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Examination, prevention and treatment of osteoporosis in patients with inflammatory bowel disease: recommendations and reality

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappa B ligand on adult T-cell leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Interleukin-2 stimulates osteoclastic activity: increased acid production and radioactive calcium release

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

IL-2 and autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Langerhans cell histiocytosis in children: does soluble interleukin-2-receptor correlate with both disease extent and activity?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Interleukin-2 production and bone-resorption activity in vitro by unstimulated lymphocytes extracted from chronically-inflamed human periodontal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

RANK-L and RANK: T cells, bone loss, and mammalian evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

The molecular mechanism of osteoclastogenesis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

T Cell Activation Induces Human Osteoclast Formation via Receptor Activator of Nuclear Factor κB Ligand-Dependent and -Independent Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900326-1

7 January 2021

10.1016/S1074-7613(03)00326-1

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018